Teva Pharma Stock Target Price and Analyst Consensus
| TEVA Stock | USD 17.84 0.70 3.78% |
The current analyst and expert consensus on Teva Pharma is Strong Buy, with 6 strong buy opinions. The current projected Teva Pharma target price consensus is 24.17 with 11 analyst opinions. Check out Macroaxis Advice on Teva Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Teva Pharma Industries analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Teva Pharma executives and customers to further validate their buy or sell advice. Teva Pharma buy-or-sell recommendation module provides average expert sentiment on the projected Teva Pharma Industries target price to derive its highest and lowest estimates based on projected price volatility of 4.3937.
Lowest Forecast 21.99 | Highest Forecast 26.83 | Target Price 24.17 |
Teva |
It's important to approach Teva Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Teva Pharma Target Price Consensus
Teva target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Teva Pharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 11 | Strong Buy |
Most Teva analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Teva stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Teva Pharma Industries, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTeva Pharma Target Price Projection
Teva Pharma's current and average target prices are 17.84 and 24.17, respectively. The current price of Teva Pharma is the price at which Teva Pharma Industries is currently trading. On the other hand, Teva Pharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Teva Pharma Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Teva Pharma Target Price
Teva Pharma Analyst Ratings
Teva Pharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Teva Pharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Teva Pharma's financials, market performance, and future outlook by experienced professionals. Teva Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Teva Pharma price targets
Teva Pharma's stock target price is an estimate of its future price, usually made by analysts. Using Teva Pharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Teva Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Teva Pharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Teva Pharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Teva Pharma is a key component of Teva Pharma valuation and have some predictive power on the future returns of a Teva Pharma.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Power Assets Invested over 300 shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Business Services Invested over 100 shares | |
 | Adviser Favorites Invested few shares | |
 | Banking Invested over 30 shares | |
 | Momentum Invested over 60 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Manufacturing Invested over 30 shares | |
Check out Macroaxis Advice on Teva Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Please note, the presentation of Teva Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teva Pharma's management manipulating its earnings.